Cerebral white matter burden is linked to cognitive function in patients undergoing hemodialysis

References

• Stevens LA, Viswanathan G, Weiner DE. Chronic kidney disease and end-stage renal disease in the elderly ­population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis. 2010;17(4):1–12. doi: 10.1053/j.ackd.2010.03.010.
   PubMed Web of Science ®Google Scholar
• Hannan M, Steffen A, Quinn L, et al. The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review. J Nephrol. 2019;32(2):211–230. doi: 10.1007/s40620-018-0494-2.
   PubMed Web of Science ®Google Scholar
• Vanderlinden JA, Ross-White A, Holden R, et al. Quantifying cognitive dysfunction across the spectrum of end-stage kidney disease: a systematic review and meta-analysis. Nephrology. 2019;24(1):5–16. doi: 10.1111/nep.13448.
   PubMed Web of Science ®Google Scholar
• Drew DA, Tighiouart H, Rollins J, et al. Evaluation of screening tests for cognitive impairment in patients receiving maintenance hemodialysis. J Am Soc Nephrol. 2020;31(4):855–864. doi: 10.1681/ASN.2019100988.
   PubMed Web of Science ®Google Scholar
• Yaffe K, Ackerson L, Kurella Tamura M, et al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010;58(2):338–345. doi: 10.1111/j.1532-5415.2009.02670.x.
   PubMed Web of Science ®Google Scholar
• Berger I, Wu S, Masson P, et al. Cognition in chronic kidney disease: a systematic review and meta-analysis. BMC Med. 2016;14(1):206. doi: 10.1186/s12916-016-0745-9.
   PubMed Web of Science ®Google Scholar
• Murray AM, Bell EJ, Tupper DE, et al. The brain in kidney disease (BRINK) cohort study: design and baseline cognitive function. Am J Kidney Dis. 2016;67(4):593–600. doi: 10.1053/j.ajkd.2015.11.008.
   PubMed Web of Science ®Google Scholar
• O'Lone E, Connors M, Masson P, et al. Cognition in people with End-Stage kidney disease treated with hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2016;67(6):925–935. doi: 10.1053/j.ajkd.2015.12.028.
   PubMed Web of Science ®Google Scholar
• Erten-Lyons D, Woltjer R, Kaye J, et al. Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology. 2013;81(11):977–983. doi: 10.1212/WNL.0b013e3182a43e45.
   PubMed Web of Science ®Google Scholar
• Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–356. doi: 10.2214/ajr.149.2.351.
   PubMed Web of Science ®Google Scholar
• Sudo FK, Alves CE, Alves GS, et al. White matter hyperintensities, executive function and global cognitive performance in vascular mild cognitive impairment. Arq Neuropsiquiatr. 2013;71(7):431–436. doi: 10.1590/0004-282X20130057.
   PubMed Web of Science ®Google Scholar
• Wieczorek J, Mizia-Stec K, Lasek-Bal A, et al. CHA2DS2-Vasc score, age and body mass index as the main risk factors of hyperintense brain lesions in ­asymptomatic patients with paroxysmal non-valvular atrial fibrillation. Int J Cardiol. 2016;215:476–481. doi: 10.1016/j.ijcard.2016.04.094.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao Y, Mao J. Association between the extent of white matter damage and early cognitive impairment following acute ischemic stroke. Exp Ther Med. 2017;13(3):909–912. doi: 10.3892/etm.2017.4035.
   PubMed Web of Science ®Google Scholar
• Claus JJ, Coenen M, Staekenborg SS, et al. Cerebral white matter lesions have low impact on cognitive function in a large elderly memory clinic population. J Alzheimers Dis. 2018;63(3):1129–1139. doi: 10.3233/JAD-171111.
   PubMed Web of Science ®Google Scholar
• Kynast J, Lampe L, Luck T, et al. White matter hyperintensities associated with small vessel disease impair ­social cognition beside attention and memory. J Cereb Blood Flow Metab. 2018;38(6):996–1009. doi: 10.1177/0271678X17719380.
   PubMed Web of Science ®Google Scholar
• Fruhwirth V, Enzinger C, Fandler-Höfler S, et al. Baseline white matter hyperintensities affect the course of cognitive function after small vessel disease-related stroke: a prospective observational study. Eur J Neurol. 2021;28(2):401–410. doi: 10.1111/ene.14593.
   PubMed Web of Science ®Google Scholar
• Agarwal P, Panda AK, Jena S, et al. Correlation of cerebral atrophy and white matter hyperintensity burden in MRI with clinical cognitive decline. Siriraj Med J. 2022;74(5):323–329. doi: 10.33192/Smj.2022.39.
   Google Scholar
• Odagiri G, Sugawara N, Kikuchi A, et al. Cognitive function among hemodialysis patients in Japan. Ann Gen Psychiatry. 2011;10(1):20. doi: 10.1186/1744-859X-10-20.
   PubMedGoogle Scholar
• Jung S, Lee YK, Choi SR, et al. Relationship between cognitive impairment and depression in dialysis patients. Yonsei Med J. 2013;54(6):1447–1453. doi: 10.3349/ymj.2013.54.6.1447.
   PubMed Web of Science ®Google Scholar
• Fadili W, Al Adlouni A, Louhab N, et al. Prevalence and risk factors of cognitive dysfunction in chronic hemodialysis patients. Aging Ment Health. 2014;18(2):207–211. doi: 10.1080/13607863.2013.823375.
   PubMed Web of Science ®Google Scholar
• Tiffin-Richards FE, Costa AS, Holschbach B, et al. The montreal cognitive assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLOS One. 2014;9(10):e106700. doi: 10.1371/journal.pone.0106700.
   PubMed Web of Science ®Google Scholar
• Lin KN, Wang PN, Liu CY, et al. Cutoff scores of the cognitive abilities screening instrument, chinese version in screening of dementia. Dement Geriatr Cogn Disord. 2002;14(4):176–182. doi: 10.1159/000066024.
   PubMed Web of Science ®Google Scholar
• Vasconcellos LF, Pereira JS, Adachi M, et al. Correlation of MRI visual scales with neuropsychological profile in mild cognitive impairment of parkinson’s disease. Parkinsons Dis. 2017;2017:7380102. doi: 10.1155/2017/7380102.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Kitamura M, Hayashida M, et al. Survival and cognitive deterioration in elderly patients undergoing hemodialysis. Geriatr Gerontol Int. 2023;23(2):111–116. doi: 10.1111/ggi.14531.
   PubMed Web of Science ®Google Scholar
• Wei CS, Yan CY, Yu XR, et al. Association between white matter hyperintensities and chronic kidney disease: a systematic review and Meta-Analysis. Front Med (Lausanne). 2022;9:770184. doi: 10.3389/fmed.2022.770184.
   PubMedGoogle Scholar
• Lin YT, Wu PH, Lee HH, et al. Indole-3 acetic acid ­increased risk of impaired cognitive function in patients receiving hemodialysis. Neurotoxicology. 2019;73:85–91. doi: 10.1016/j.neuro.2019.02.019.
   PubMed Web of Science ®Google Scholar
• Makino T, Umegaki H, Suzuki Y, et al. Relationship ­between small cerebral white matter lesions and cognitive function in patients with alzheimer’s disease and amnestic mild cognitive impairment. Geriatr Gerontol Int. 2014;14(4):819–826. doi: 10.1111/ggi.12176.
   PubMed Web of Science ®Google Scholar
• Mimenza-Alvarado A, Aguilar-Navarro SG, Yeverino-Castro S, et al. Neuroimaging characteristics of small-vessel disease in older adults with normal cognition, mild cognitive impairment, and alzheimer disease. Dement Geriatr Cogn Dis Extra. 2018;8(2):199–206. doi: 10.1159/000488705.
   PubMedGoogle Scholar
• Scheppach JB, Wu A, Gottesman RF, et al. Association of kidney function measures with signs of neurodegeneration and small vessel disease on brain magnetic resonance imaging: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2023;81(3):261–269.e1. doi: 10.1053/j.ajkd.2022.07.013.
   PubMed Web of Science ®Google Scholar
• Garnier-Crussard A, Desestret V, Cotton F, et al. White matter hyperintensities in ageing: pathophysiology, associated cognitive disorders and prevention. Rev Med Interne. 2020;41(7):475–484. doi: 10.1016/j.revmed.2020.02.009.
   PubMed Web of Science ®Google Scholar
• Thorn LM, Shams S, Gordin D, et al. Clinical and MRI features of cerebral small-vessel disease in type 1 diabetes. Diabetes Care. 2019;42(2):327–330. doi: 10.2337/dc18-1302.
   PubMed Web of Science ®Google Scholar
• Debette S, Schilling S, Duperron MG, et al. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol. 2019;76(1):81–94. doi: 10.1001/jamaneurol.2018.3122.
   PubMed Web of Science ®Google Scholar
• Thal DR, Attems J, Ewers M. Spreading of amyloid, tau, and microvascular pathology in alzheimer’s disease: findings from neuropathological and neuroimaging studies. J Alzheimers Dis. 2014;42(Suppl 4): s 421–9. doi: 10.3233/JAD-141461.
   Google Scholar
• van Westen D, Lindqvist D, Blennow K, et al. Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET. Sci Rep. 2016;6(1):20709. doi: 10.1038/srep20709.
   PubMedGoogle Scholar
• Vogels SC, Emmelot-Vonk MH, Verhaar HJ, et al. The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review. Maturitas. 2012;71(4):331–336. doi: 10.1016/j.maturitas.2012.01.008.
   PubMed Web of Science ®Google Scholar
• Shima H, Ishimura E, Naganuma T, et al. Decreased kidney function is a significant factor associated with silent cerebral infarction and periventricular hyperintensities. Kidney Blood Press Res. 2011;34(6):430–438. doi: 10.1159/000328722.
   PubMed Web of Science ®Google Scholar
• Li Q, Yang Y, Reis C, et al. Cerebral small vessel disease. Cell Transplant. 2018;27(12):1711–1722. doi: 10.1177/0963689718795148.
   PubMed Web of Science ®Google Scholar
• De Silva TM, Miller AA. Cerebral small vessel disease: targeting oxidative stress as a novel therapeutic strategy? Front Pharmacol. 2016;7:61. doi: 10.3389/fphar.2016.00061.
   PubMed Web of Science ®Google Scholar
• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. doi: 10.1016/S1474-4422(10)70104-6.
   PubMed Web of Science ®Google Scholar
• de Leeuw FE, Barkhof F, Scheltens P. White matter ­lesions and hippocampal atrophy in Alzheimer’s disease. Neurology. 2004;62(2):310–312. doi: 10.1212/01.wnl.0000103289.03648.ad.
   PubMed Web of Science ®Google Scholar
• Muller M, Appelman APA, van der Graaf Y, et al. Brain atrophy and cognition: interaction with cerebrovascular pathology? Neurobiol Aging. 2011;32(5):885–893. doi: 10.1016/j.neurobiolaging.2009.05.005.
   PubMed Web of Science ®Google Scholar
• Carmichael O, Mungas D, Beckett L, et al. MRI predictors of cognitive change in a diverse and carefully characterized elderly population. Neurobiol Aging. 2012;33(1):83–95. doi: 10.1016/j.neurobiolaging.2010.01.021.
   PubMed Web of Science ®Google Scholar
• Birdsill AC, Koscik RL, Jonaitis EM, et al. Regional white matter hyperintensities: aging, Alzheimer’s disease risk, and cognitive function. Neurobiol Aging. 2014;35(4):769–776. doi: 10.1016/j.neurobiolaging.2013.10.072.
   PubMed Web of Science ®Google Scholar
• Smith CD, Johnson ES, Van Eldik LJ, et al. Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer’s disease. Brain Behav. 2016;6(3):e00438.
   PubMed Web of Science ®Google Scholar
• Prins ND, van Straaten EC, van Dijk EJ, et al. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology. 2004;62(9):1533–1539. doi: 10.1212/01.wnl.0000123264.40498.b6.
   PubMed Web of Science ®Google Scholar
• van Straaten EC, Fazekas F, Rostrup E, et al. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke. 2006;37(3):836–840. doi: 10.1161/01.STR.0000202585.26325.74.
   PubMed Web of Science ®Google Scholar
• Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967–972. doi: 10.1136/jnnp.55.10.967.
   PubMed Web of Science ®Google Scholar
• Gouw AA, van der Flier WM, van Straaten EC, et al. Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis. 2008;25(3):247–253. doi: 10.1159/000113863.
   PubMed Web of Science ®Google Scholar
• Kim KW, MacFall JR, Payne ME. Classification of white matter lesions on magnetic resonance imaging in ­elderly persons. Biol Psychiatry. 2008;64(4):273–280. doi: 10.1016/j.biopsych.2008.03.024.
   PubMed Web of Science ®Google Scholar
• Griffanti L, Jenkinson M, Suri S, et al. Classification and characterization of periventricular and deep white matter hyperintensities on MRI: a study in older adults. Neuroimage. 2018;170:174–181. doi: 10.1016/j.neuroimage.2017.03.024.
   PubMed Web of Science ®Google Scholar
• De Groot JC, De Leeuw FE, Oudkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol. 2002;52(3):335–341. doi: 10.1002/ana.10294.
   PubMed Web of Science ®Google Scholar
• van den Heuvel DM, ten Dam VH, de Craen AJ, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry. 2006;77(2):149–153. doi: 10.1136/jnnp.2005.070193.
   PubMed Web of Science ®Google Scholar
• Silbert LC, Howieson DB, Dodge H, et al. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology. 2009;73(2):120–125. doi: 10.1212/WNL.0b013e3181ad53fd.
   PubMed Web of Science ®Google Scholar
• Owen JP, Wang MB, Mukherjee P. Periventricular white matter is a nexus for network connectivity in the human brain. Brain Connect. 2016;6(7):548–557. doi: 10.1089/brain.2016.0431.
   PubMedGoogle Scholar
• Darvesh S, Freedman M. Subcortical dementia: a neurobehavioral approach. Brain Cogn. 1996;31(2):230–249. doi: 10.1006/brcg.1996.0043.
   PubMed Web of Science ®Google Scholar
• Selden NR, Gitelman DR, Salamon-Murayama N, et al. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998;121(12):2249–2257. doi: 10.1093/brain/121.12.2249.
   PubMed Web of Science ®Google Scholar
• Guo H, Liu W, Li H, et al. Structural and functional brain changes in hemodialysis patients with End-Stage renal disease: DTI analysis results and ALFF analysis results. Int J Nephrol Renovasc Dis. 2021;14:77–86. doi: 10.2147/IJNRD.S295025.
   PubMed Web of Science ®Google Scholar